NPPA brings down prices of anti cancer drugs upto 85%
Government of India has brought 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30 per cent, which would reduce their retail prices […]
Insights
USFDA promotes generic medicines
USFDA is allaying fears of generic medicine to provide a boost to Indian pharmaceutical sector. Apparently, over 90% of United States drug market is dominated […]
Challenges faced by bulk drug manufacturers in India
India produces over 1/5th of bulk drug production in the world. However, the bulk drugs manufacturers are facing regulatory hurdles in many area. Currently, irrespective […]
Genetics the cause for susceptibility of South Asians over Africans
Genetics is the cause for dengue vulnerability of South and North East Asiana. While Africans are more immune to Dengue Shock Syndrome and other severe […]
Indian Government to study impact of FDI in pharma
Indian government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies. In recent years, there […]
Indian Pharma Industry market estimated at USD 15 billion
Indian Pharma industry market is estimated at USD 15 billion and is growing at a rate of 12% per annum in September 2015. Top 20 […]
Indian Pharma industry moving towards formulations
Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now […]
Contract & Research Manufacturing Services – India’s edge
India got a huge potential in CRAMS (Contract Research & Manufacturing Services) . Since 1990’s more MNCs find India for the following reasons viz. Larger […]